Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Limited data exists for: Understudied Populations: Adults over 75 years (increased sensitivity to appetite suppression) Adolescents (ongoing development considerations) Individuals with BMI under 27 (insufficient safety data) Pregnant or lactating individuals (no safety data) Individuals with significant psychiatric conditions Gender Considerations: Research suggests some metabolic peptides may show differential effects between males and females, though data for cagrilintide and retatrutide specifically remains limited
BPC-157 is not approved by Health Canada for human use
Available in 10mg/10mg lyophilized vials (20mg total)
Headaches : Generally mild and often will ease as the body adjusts to the compound
US$ 25.45
US$ 22.11
/assets/images/provider/photos/1922393.jpg)
US$ 23.04
US$ 25.21
US$ 27.56
US$ 27.34
US$ 28.48
US$ 21.09
US$ 27.69
